Literature DB >> 23523916

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

Wenxing Qin1, Qiusheng Ren, Te Liu, Yongyi Huang, Jiejun Wang.   

Abstract

Previous cDNA microarrays indicated that CLDN1 (claudin-1) is an important gene for ovarian cancer-initiating cell (OCIC) invasion and adhesion. Here, we show that the downregulation of miR-155 in OCICs correlates with CLDN1 overexpression and the suppression of OCIC invasion. Luciferase assays indicate that miR-155 targets CLDN1 mRNA on the 3' UTR. CLDN1 mRNA and claudin-1 protein expression were significantly decreased in miR-155-OCICs. Proliferation assays and Transwell migration assays show that miR-155 significantly suppresses the proliferative and invasive capacity of OCICs. Furthermore, miR-155 suppresses the growth of OCIC xenograft tumors. Thus, overexpression of miR-155 may prevent tumorigenesis in human ovarian cancer through downregulation of CLDN1.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523916     DOI: 10.1016/j.febslet.2013.03.023

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  59 in total

1.  Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells.

Authors:  Zhi-hua Yu; Te Liu; Yan-hui Zhao; Yong-yi Huang; Yong-tao Gao
Journal:  Tumour Biol       Date:  2014-01-10

Review 2.  OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.

Authors:  Alexander A Svoronos; Donald M Engelman; Frank J Slack
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

3.  The Significance of Relative Claudin Expression in Odontogenic Tumors.

Authors:  Ekarat Phattarataratip; Kraisorn Sappayatosok
Journal:  Head Neck Pathol       Date:  2019-08-31

4.  Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors.

Authors:  Jason Harquail; Nicolas LeBlanc; Carine Landry; Nicolas Crapoulet; Gilles A Robichaud
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-21       Impact factor: 2.673

5.  Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer.

Authors:  Xudong Chen; Guoqiang Zhao; Fuqing Wang; Fenglan Gao; Hailan Luo; Yuanyuan Wang; Yuwen Du; Xiaonan Chen; Changgui Xue; Ziming Dong; Guohua Song
Journal:  Tumour Biol       Date:  2014-08-06

6.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27

7.  MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.

Authors:  Zhijun Ma; Yulan Ma; Qinghua Xia; Yong Li; Ruidong Li; Weilong Chang; Jinhuang Chen; Zhengwei Leng; Kaixiong Tao
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-08       Impact factor: 4.553

Review 8.  Claudins in cancer: bench to bedside.

Authors:  Makoto Osanai; Akira Takasawa; Masaki Murata; Norimasa Sawada
Journal:  Pflugers Arch       Date:  2016-09-13       Impact factor: 3.657

9.  MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3.

Authors:  Heying Chu; Xudong Chen; Huaqi Wang; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Ping Li; Juan Li; Jingxia Chang; Guoqiang Zhao; Guojun Zhang
Journal:  Tumour Biol       Date:  2013-11-29

10.  miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells.

Authors:  X-H He; W Zhu; P Yuan; S Jiang; D Li; H-W Zhang; M-F Liu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.